Rhodiola crenulata
Rhodiola crenulata · Accepted scientific name
Scientific literature: Very Sparse (8 studies) · ★☆☆☆☆
Rhodiola crenulata is a medicinal plant primarily utilized for its potent therapeutic properties derived from its root and rhizome. Rich in bioactive compounds such as salidroside, flavonoids, and adenosine phosphates, this species offers diverse pharmacological benefits. It is widely recognized for its neuroprotective, antidepressant, and antifatigue activities, making it a valuable subject in managing conditions like Alzheimer's disease. Additionally, preparations like Rhodiolae Crenulatae Radix et Rhizoma extract are studied for their antiarrhythmic and antioxidant potential. Through various forms such as RCE, this plant serves as a powerful natural resource for addressing cardiac arrhythmias and oxidative stress.
- Synonyms
- Sedum Rotundatum Var. Oblongatum · Sedum Euryphyllum · 7 more
- Common names
- Not available
- Family
- Crassulaceae
- Distribution
- Africa
- Plant Parts
- Root · Rhizome
Classification
Common Names
Rhodiola crenulata is a unique botanical species known by several distinct common names across different regions. In some areas, it is frequently referred to as da hua hong jing tian. It is also widely identified by its Chinese name 大花紅景天. Furthermore, the plant is recognized by the specific designation 寬瓣紅景天. Understanding these various names is essential for anyone studying the diverse terminology used to describe this plant.
Sources: Catalogue of Life (COL)
Synonyms
Rhodiola crenulata is a botanical species characterized by a complex history of taxonomic classifications. Throughout various studies, it has been identified by several synonyms, including Rhodiola euryphylla and Rhodiola megalophylla. The plant is also frequently referred to in scientific literature as Rhodiola rotundata. Additionally, its classification has historically extended into the Sedum genus as both Sedum crenulatum and Sedum euryphyllum. Understanding these diverse nomenclatures is essential for accurate identification within the plant kingdom.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Rhodiola crenulata is a unique organism that belongs to the vast kingdom Plantae. Within this expansive realm, it is classified under the class Equisetopsida and the order Saxifragales. Its specific lineage continues through the family Crassulaceae, which defines its botanical characteristics. This plant is further identified by its membership in the genus Rhodiola. Understanding these biological relationships helps botanists categorize its role within the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Saxifragales |
| Family | Crassulaceae |
| Genus | Rhodiola |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Rhodiola crenulata is a resilient plant found across a diverse range of Asian landscapes. Its distribution spans the temperate regions of China, including specific locales such as South-Central China, Qinghai, and Tibet. Beyond these northern reaches, the species also thrives within the tropical climates of the Indian Subcontinent. Specifically, it can be identified growing throughout the rugged terrain of the East Himalaya and the nation of Nepal. This broad geographic presence highlights the plant's remarkable ability to adapt to varying altitudes and environmental conditions.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Rhodiola crenulata grows in a distinct herb form, characterized by its delicate yet resilient structure. This plant is entirely self-supporting, allowing it to maintain its upright posture within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Rhodiola crenulata is a versatile medicinal plant that has demonstrated a wide range of therapeutic activities in various scientific studies. Research indicates that the plant possesses significant neuroprotective properties, particularly in mitigating neuronal damage and cognitive deficits associated with Alzheimer's disease. Beyond brain health, it has been identified as a promising candidate for antiarrhythmic intervention to help manage irregular heartbeats. The plant is also recognized for its traditional uses as an antidepressant and an antifatigue agent to support mental and physical well-being. Furthermore, recent investigations into its antineoplastic effects suggest it may play a role in inhibiting the proliferation of aggressive cancer cells, such as glioblastoma.
Compounds
Rhodiola crenulata is a highly valued alpine medicinal plant characterized by a diverse array of bioactive secondary metabolites. Central to its medicinal profile is the presence of salidroside, a key component that researchers often target for optimized extraction and quantitative analysis. The plant's complex chemical makeup also includes various flavonoids and condensed tannins, which play significant roles in its metabolic pathways. Furthermore, metabolomic studies have identified the presence of adenosine phosphates and free fatty acids within its biological structure. Understanding these specific relationships provides critical insights into how the plant adapts to extreme high-altitude environments.
Conditions
Rhodiola crenulata serves as a potential therapeutic agent for treating Alzheimer's disease by protecting hippocampal neurons from mitochondrial dysfunction and apoptosis. This medicinal plant also demonstrates efficacy in treating D-galactose-induced aging by promoting neuronal survival and resisting age-related neurotoxicity. Furthermore, Rhodiola crenulata treats DSS-induced colitis in mice by reducing pro-inflammatory factors and restoring gut microbiome diversity. Its application also effectively treats DSS-induced epithelial apoptosis through the upregulation of essential tight junction proteins. Together, these findings highlight the diverse neuroprotective and anti-inflammatory capabilities of the plant.
Preparations
Rhodiola crenulata is prepared as an extract, often referred to in the literature as RCE or Rhodiola crenulata extract (RCE). The medicinal plant is also prepared as Rhodiolae Crenulatae Radix et Rhizoma, which serves as the original source recognized in the China Pharmacopoeia. Various methodologies are used to obtain its bioactive components, including preparation via water-extraction. These diverse preparation methods allow for the isolation of specific compounds like salidroside and polysaccharides for therapeutic research.
Parts used
Rhodiola crenulata is a highly valued medicinal plant that is utilized globally for its adaptogenic properties. The primary components used in traditional medicine and pharmaceutical research are the plant's root and rhizome. Scientific studies have demonstrated that extracts derived from these parts can offer significant neuroprotective benefits, such as mitigating mitochondrial dysfunction in Alzheimer's models. Furthermore, high-performance liquid chromatography is frequently employed to quantitatively analyze active compounds like salidroside within the roots. Because the medicinal market for these specific plant parts can be chaotic, researchers are increasingly using DNA barcoding to ensure the authentic identification of the species.